Creative Medical Technology Holdings, Inc.

NasdaqCM:CELZ Stock Report

Market Cap: US$3.6m

Creative Medical Technology Holdings Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Tim Warbington

Chief executive officer

US$522.6k

Total compensation

CEO salary percentage63.1%
CEO tenure8.8yrs
CEO ownership0.7%
Management average tenureno data
Board average tenure3.9yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Tim Warbington's remuneration changed compared to Creative Medical Technology Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$5m

Jun 30 2024n/an/a

-US$6m

Mar 31 2024n/an/a

-US$5m

Dec 31 2023US$523kUS$330k

-US$5m

Sep 30 2023n/an/a

-US$10m

Jun 30 2023n/an/a

-US$9m

Mar 31 2023n/an/a

-US$10m

Dec 31 2022US$469kUS$330k

-US$10m

Sep 30 2022n/an/a

-US$8m

Jun 30 2022n/an/a

-US$9m

Mar 31 2022n/an/a

-US$10m

Dec 31 2021US$99kUS$99k

US$19m

Compensation vs Market: Tim's total compensation ($USD522.62K) is about average for companies of similar size in the US market ($USD653.16K).

Compensation vs Earnings: Tim's compensation has increased whilst the company is unprofitable.


CEO

Tim Warbington (62 yo)

8.8yrs

Tenure

US$522,620

Compensation

Mr. Timothy Warbington, also known as Tim, is Co-Founder of Creative Medical Technology Holdings, Inc. and serves as its Chief Executive Officer since February 2016 and serves as its President since May 18...


Board Members

NamePositionTenureCompensationOwnership
Timothy Warbington
Co-Founder8.8yrsUS$522.62k0.70%
$ 25.3k
Donald Dickerson
Senior VP8.8yrsUS$467.25k0.00097%
$ 35.1
Susan Snow
Independent Director3yrsUS$120.00kno data
Boris Reznik
Member of Scientific Advisory Board3.9yrsno datano data
Camillo Ricordi
Member of Scientific Advisory Board3.6yrsno datano data
Santosh Kesari
Member of Scientific Advisory Board8yrsno datano data
Michael Finger
Independent Director3yrsUS$80.00k0.11%
$ 3.8k
Timothy Henry
Member of Scientific Advisory Board6.5yrsno datano data
Bruce Urdang
Independent Director3yrsUS$100.00kno data

3.9yrs

Average Tenure

66yo

Average Age

Experienced Board: CELZ's board of directors are considered experienced (3.9 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 09:55
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Creative Medical Technology Holdings, Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jonathan AschoffRoth MKM